June 8, 2020 / 11:22 AM / 2 months ago

BRIEF-Arch Biopartners Submits IND Application For Metablok

June 8 (Reuters) - Arch Biopartners Inc:

* ARCH BIOPARTNERS SUBMITS INVESTIGATIONAL NEW DRUG APPLICATION TO THE FDA FOR METABLOK (LSALT PEPTIDE)

* ARCH BIOPARTNERS -SUBMITTED IND APPLICATION FOR METABLOK TO CONDUCT PHASE II TRIAL TO PREVENT ACUTE ORGAN INFLAMMATION, INJURY EXPERIENCED BY PATIENTS WITH COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below